Glimepiride & Metformin Prolonged Release Tablets – Glumight M1 Tablets

Glumight-M1
Composition: Glimepiride & Metformin Prolonged Release Tablets

Glumight-M1 — Glimepiride & Metformin Prolonged Release Tablets is used for the management of type 2 diabetes mellitus. Glimepiride helps stimulate insulin release from the pancreas, while metformin prolonged-release reduces glucose production and improves insulin sensitivity. This combination provides steady blood sugar control, helps maintain stable glucose levels, and reduces the risk of diabetes-related complications when taken regularly with proper diet and lifestyle changes.

Key Points of Glimepiride & Metformin Prolonged Release Tablets – Glumight M1 Tablets: Improves Glycaemic Control with Sustained Release Support

Active Ingredients:
Glimepiride — Sulfonylurea
Metformin (Prolonged-Release) — Biguanide antidiabetic agent
Therapeutic Benefits: Helps manage type 2 diabetes mellitus by enhancing insulin secretion and improving insulin sensitivity. Supports effective control of both fasting and post-meal blood glucose levels for better overall glycaemic balance.
Better Tolerability: The prolonged-release Metformin formulation ensures gradual drug release, helping reduce gastrointestinal discomfort and improving treatment adherence when used under medical supervision.
Mode of Action: Glimepiride stimulates insulin release from pancreatic beta cells, while Metformin (PR) reduces hepatic glucose production and enhances peripheral insulin sensitivity—together delivering sustained and balanced blood sugar control.

Can be prescribed by:

• Diabetologists
• Endocrinologists
• General Physicians.
• Healthcare practitioner

Disclaimer: To be used strictly under the guidance of a qualified healthcare professional. For prescription use only. Not intended for public marketing or promotion only.